# Zinc Supplementation in Shigella Patients

> **NCT00321126** · PHASE3 · COMPLETED · sponsor: **International Centre for Diarrhoeal Disease Research, Bangladesh** · enrollment: 56 (—)

## Conditions studied

- Testing Effect of Intervention

## Interventions

- **DRUG:** Children in the zinc group received 20 mg of elemental zinc as acetate per day in a twice-daily dose for two weeks.

## Key facts

- **NCT ID:** NCT00321126
- **Lead sponsor:** International Centre for Diarrhoeal Disease Research, Bangladesh
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-01
- **Primary completion:** —
- **Final completion:** 2002-04
- **Target enrollment:** 56 (—)
- **Last updated:** 2006-05-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00321126

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00321126, "Zinc Supplementation in Shigella Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00321126. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*